Elias J Anaissie

Summary

Affiliation: University of Arkansas for Medical Sciences
Country: USA

Publications

  1. ncbi Outcome from mechanical ventilation after autologous peripheral blood stem cell transplantation
    Basheer Y Khassawneh
    Division of Pulmonary and Critical Care Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA
    Chest 121:185-8. 2002
  2. ncbi Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt
    Elias J Anaissie
    Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA
    Clin Infect Dis 43:1031-9. 2006
  3. ncbi When a paradoxical increase in serum galactomannan antigen during caspofungin therapy is not paradoxical after all
    Marisa H Miceli
    Clin Infect Dis 44:757-60; author reply 760-1. 2007
  4. ncbi Immune reconstitution inflammatory syndrome in cancer patients with pulmonary aspergillosis recovering from neutropenia: Proof of principle, description, and clinical and research implications
    Marisa H Miceli
    Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA
    Cancer 110:112-20. 2007
  5. ncbi A bad bug takes on a new role as a cause of ventilator-associated pneumonia
    Elias J Anaissie
    Am J Respir Crit Care Med 177:1-2. 2008
  6. ncbi Diagnosis and therapy of fungal infection in patients with leukemia--new drugs and immunotherapy
    Elias J Anaissie
    Myeloma Institute for Research and Therapy, The University of Arkansas for Medical Sciences, 4301 Markham Street, Mail Slot 776, Little Rock, Arkansas 72205 7101, USA
    Best Pract Res Clin Haematol 21:683-90. 2008
  7. ncbi The natural history of respiratory syncytial virus infection in cancer and transplant patients: implications for management
    Elias J Anaissie
    Myeloma Institute for Research and Therapy, The University of Arkansas for Medical Sciences, Little Rock 72205, USA
    Blood 103:1611-7. 2004
  8. ncbi Prophylactic recombinant erythropoietin therapy and thalidomide are predictors of venous thromboembolism in patients with multiple myeloma: limited effectiveness of thromboprophylaxis
    Elias J Anaissie
    Myeloma Institute for Research and Therapy, Division of Supportive Care, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA
    Cancer 118:549-57. 2012
  9. ncbi Pathogenic Aspergillus species recovered from a hospital water system: a 3-year prospective study
    Elias J Anaissie
    Myeloma and Transplantation Research Center, Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA
    Clin Infect Dis 34:780-9. 2002
  10. ncbi The hospital water supply as a source of nosocomial infections: a plea for action
    Elias J Anaissie
    Myeloma and Transplantation Research Center, University of Arkansas for Medical Sciences, Little Rock 72205, USA
    Arch Intern Med 162:1483-92. 2002

Detail Information

Publications35

  1. ncbi Outcome from mechanical ventilation after autologous peripheral blood stem cell transplantation
    Basheer Y Khassawneh
    Division of Pulmonary and Critical Care Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA
    Chest 121:185-8. 2002
    ....
  2. ncbi Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt
    Elias J Anaissie
    Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA
    Clin Infect Dis 43:1031-9. 2006
  3. ncbi When a paradoxical increase in serum galactomannan antigen during caspofungin therapy is not paradoxical after all
    Marisa H Miceli
    Clin Infect Dis 44:757-60; author reply 760-1. 2007
  4. ncbi Immune reconstitution inflammatory syndrome in cancer patients with pulmonary aspergillosis recovering from neutropenia: Proof of principle, description, and clinical and research implications
    Marisa H Miceli
    Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA
    Cancer 110:112-20. 2007
    ..In this study, the authors used sequential galactomannan testing to distinguish IRIS responses from progressive aspergillosis...
  5. ncbi A bad bug takes on a new role as a cause of ventilator-associated pneumonia
    Elias J Anaissie
    Am J Respir Crit Care Med 177:1-2. 2008
  6. ncbi Diagnosis and therapy of fungal infection in patients with leukemia--new drugs and immunotherapy
    Elias J Anaissie
    Myeloma Institute for Research and Therapy, The University of Arkansas for Medical Sciences, 4301 Markham Street, Mail Slot 776, Little Rock, Arkansas 72205 7101, USA
    Best Pract Res Clin Haematol 21:683-90. 2008
    ..Immunotherapy with hematopoietic growth factors and interferon-gamma has been effective in some patients. Finally, donor-stimulated granulocyte transfusions may be useful in this patient population, but further research is required...
  7. ncbi The natural history of respiratory syncytial virus infection in cancer and transplant patients: implications for management
    Elias J Anaissie
    Myeloma Institute for Research and Therapy, The University of Arkansas for Medical Sciences, Little Rock 72205, USA
    Blood 103:1611-7. 2004
    ..RSV infection may not necessarily be a contraindication for APBSCT or an indication for therapy with aerosolized ribavirin and IVIG...
  8. ncbi Prophylactic recombinant erythropoietin therapy and thalidomide are predictors of venous thromboembolism in patients with multiple myeloma: limited effectiveness of thromboprophylaxis
    Elias J Anaissie
    Myeloma Institute for Research and Therapy, Division of Supportive Care, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA
    Cancer 118:549-57. 2012
    ..As a result, most patients receive thromboprophylaxis with low molecular weight heparin (LMWH). The purpose of this retrospective study was to identify risk factors for VTE in NDMM and evaluate the effectiveness of LMWH...
  9. ncbi Pathogenic Aspergillus species recovered from a hospital water system: a 3-year prospective study
    Elias J Anaissie
    Myeloma and Transplantation Research Center, Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA
    Clin Infect Dis 34:780-9. 2002
    ..In addition to the air, hospital water systems may be a source of nosocomial aspergillosis...
  10. ncbi The hospital water supply as a source of nosocomial infections: a plea for action
    Elias J Anaissie
    Myeloma and Transplantation Research Center, University of Arkansas for Medical Sciences, Little Rock 72205, USA
    Arch Intern Med 162:1483-92. 2002
    ..The purpose of this review is to assess the magnitude of the problem caused by waterborne nosocomial infections and to plea for immediate action for their prevention...
  11. ncbi Effects of exercise on fatigue, sleep, and performance: a randomized trial
    Elizabeth Ann Coleman
    College of Nursing, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA
    Oncol Nurs Forum 39:468-77. 2012
    ..To compare usual care with a home-based individualized exercise program (HBIEP) in patients receiving intensive treatment for multiple myeloma (MM)and epoetin alfa therapy...
  12. ncbi Pathogenic molds (including Aspergillus species) in hospital water distribution systems: a 3-year prospective study and clinical implications for patients with hematologic malignancies
    Elias J Anaissie
    Myeloma Institute for Research and Treatment, University of Arkansas for Medical Sciences, Little Rock 72205, USA
    Blood 101:2542-6. 2003
    ..Hospital water distribution systems may serve as a potential indoor reservoir of Aspergillus and other molds leading to aerosolization of fungal spores and potential exposure for patients...
  13. ncbi Effects of exercise in combination with epoetin alfa during high-dose chemotherapy and autologous peripheral blood stem cell transplantation for multiple myeloma
    Elizabeth A Coleman
    Colleges of Medicine and Nursing, University of Arkansas for Medical Sciences, Little Rock, USA
    Oncol Nurs Forum 35:E53-61. 2008
    ..To determine the effect of aerobic and strength resistance training and epoetin alfa (EPO) therapy on transfusions, stem cell collections, transplantation recovery, and multiple myeloma treatment response...
  14. ncbi Cleaning patient shower facilities: a novel approach to reducing patient exposure to aerosolized Aspergillus species and other opportunistic molds
    Elias J Anaissie
    Myeloma Institute for Research and Treatment, Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA
    Clin Infect Dis 35:E86-8. 2002
    ..In this report, we show that cleaning the floors of patient shower facilities in a bone marrow transplantation unit reduced the mean air concentrations of molds, including Aspergillus species (from 12 cfu/m3 to 4 cfu/m3; P=.0047)...
  15. ncbi Fatigue, sleep, pain, mood, and performance status in patients with multiple myeloma
    Elizabeth Ann Coleman
    College of Nursing, University of Arkansas for Medical Sciences, 4301 W Markham St, Slot 529, Little Rock, AR 72205, USA
    Cancer Nurs 34:219-27. 2011
    ..Cancer-related fatigue and insomnia are common distressing symptoms and may affect mood and performance status...
  16. ncbi Changes in quality-of-life and psychosocial adjustment among multiple myeloma patients treated with high-dose melphalan and autologous stem cell transplantation
    Allen C Sherman
    Behavioral Medicine, Winthrop P Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA
    Biol Blood Marrow Transplant 15:12-20. 2009
    ..01) and less depression (P < .05) before transplantation. Our findings emphasize the importance of early screening and intervention...
  17. ncbi Prospective study of religious coping among patients undergoing autologous stem cell transplantation
    Allen C Sherman
    Behavioral Medicine, 756, Winthrop P Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, 4301W Markham, 72205, Little Rock, AR, USA
    J Behav Med 32:118-28. 2009
    ..Results suggest that religious struggle may contribute to adverse changes in health outcomes for transplant patients, and highlight the importance of negative or strained religious responses to illness...
  18. ncbi Incidence and risk factors for lower alimentary tract mucositis after 1529 courses of chemotherapy in a homogenous population of oncology patients: clinical and research implications
    Somashekar G Krishna
    Department of Gastroenterology and Hepatology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA
    Cancer 117:648-55. 2011
    ....
  19. ncbi Diagnosis of infection of implantable central venous catheters by [18F]fluorodeoxyglucose positron emission tomography
    Marisa H Miceli
    The University of Arkansas for Medical Sciences, Myeloma Institute for Research and Therapy, Little Rock, Arkansas, USA
    Nucl Med Commun 25:813-8. 2004
    ..FDG PET may help prevent the unnecessary removal of implantable intravascular catheters and the unwarranted use of antibiotics...
  20. ncbi Pharmacokinetics and buccal mucosal concentrations of a 15 milligram per kilogram of body weight total dose of liposomal amphotericin B administered as a single dose (15 mg/kg), weekly dose (7.5 mg/kg), or daily dose (1 mg/kg) in peripheral stem cell tran
    Paul O Gubbins
    Department of Pharmacy Practice, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA
    Antimicrob Agents Chemother 53:3664-74. 2009
    ..5 mg/kg) or a single L-AMB dose (15 mg/kg) produced sufficient concentrations in plasma and highly vascular tissue to warrant further studies of the safety, efficacy, and practicality of the weekly prophylactic administration of L-AMB...
  21. ncbi Bradycardia during therapy for multiple myeloma with thalidomide
    Ibrahim Elias Fahdi
    Division of Cardiovascular Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA
    Am J Cardiol 93:1052-5. 2004
    ..Reducing the thalidomide dose appeared to alleviate symptoms in most patients...
  22. ncbi Use of a supportive care team for screening and preemptive intervention among multiple myeloma patients receiving stem cell transplantation
    Allen C Sherman
    Behavioral Medicine, University of Arkansas for Medical Sciences, 4301 West Markham, 756, Little Rock, AR 72205, USA
    Support Care Cancer 11:568-74. 2003
    ....
  23. ncbi Pharmacokinetics and safety of oral posaconazole in neutropenic stem cell transplant recipients
    Paul O Gubbins
    College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, 72205, USA
    Antimicrob Agents Chemother 50:1993-9. 2006
    ..1483). Moreover, this reduction could be overcome by increasing the total dose and dosing frequency. Posaconazole was safe and well tolerated...
  24. ncbi Mucosa or skin as source of coagulase-negative staphylococcal bacteraemia?
    Silvia F Costa
    Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock 72205, USA
    Lancet Infect Dis 4:278-86. 2004
    ....
  25. ncbi Bisphosphonates and jaw osteonecrosis: the UAMS experience
    Brett M Clarke
    Department of Otolaryngology Head and Neck Surgery, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA
    Otolaryngol Head Neck Surg 136:396-400. 2007
    ..Over the past year at least 10 case series and several case reports on osteonecrosis of the jaw (ONJ) have been published with most found in the oral surgery literature. This clinical entity is largely unknown to head and neck surgeons...
  26. ncbi Genetic diversity of human pathogenic members of the Fusarium oxysporum complex inferred from multilocus DNA sequence data and amplified fragment length polymorphism analyses: evidence for the recent dispersion of a geographically widespread clonal lineag
    Kerry O'Donnell
    National Center for Agricultural Utilization Research, U S Department of Agriculture, Peoria, IL 61604 3999, USA
    J Clin Microbiol 42:5109-20. 2004
    ..S. hospitals, providing support for the hypothesis that hospitals may serve as a reservoir for nosocomial fusarial infections...
  27. ncbi Destruction of isolates from the Pittsburgh Veterans Affairs Laboratory
    David R Snydman
    Department of Medicine, Division of Geographic Medicine and Infectious Diseases, Tufts New England Medical Center and Tufts University School of Medicine, Boston, Massachusetts, USA
    Clin Infect Dis 46:1053-9. 2008
    ..This article discusses the implications and protests such destruction as an affront to science and scientific study. A petition signed by 243 individuals accompanies this article...
  28. ncbi Emerging and less common fungal pathogens
    Rhonda V Fleming
    Division of Infectious Diseases, Boston University Medical Center, Boston, MA, USA
    Infect Dis Clin North Am 16:915-33, vi-vii. 2002
    ....
  29. ncbi Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection
    Marcio Nucci
    Department of Internal Medicine, Hematology Service, University Hospital, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
    Cancer 98:315-9. 2003
    ..0001). CONCLUSIONS: Measures to reduce the duration of neutropenia, as well as the judicious use of corticosteroids, may reduce the high mortality rate of fusariosis in patients with hematologic cancer...
  30. ncbi A phase III, randomized, double-blind, placebo-controlled, multinational trial of iseganan for the prevention of oral mucositis in patients receiving stomatotoxic chemotherapy (PROMPT-CT trial)
    Francis J Giles
    Department of Leukemia, The University of Texas, M D Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 428, Houston, TX 77030, USA
    Leuk Lymphoma 44:1165-72. 2003
    ..6 and 2.0 (P = 0.0131). Iseganan was well tolerated; no systemic absorption was detected. Iseganan is safe and may be effective in reducing UOM and its clinical sequelae...
  31. ncbi Presentation of the PATH Alliance registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infections
    David L Horn
    Division of Infectious Diseases, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA
    Diagn Microbiol Infect Dis 59:407-14. 2007
    ..As enrollment continues, additional data will be analyzed and published, which will provide valuable information concerning the epidemiology, therapy, and outcomes of IFIs...
  32. ncbi A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy
    Francis J Giles
    M D Anderson Cancer Center, Department of Leukemia, The University of Texas, 1515 Holcombe Boulevard, Box 428, Houston, TX 77030, USA
    Leuk Res 28:559-65. 2004
    ..A major impact of Iseganan on reducing stomatitis, UOM, or its clinical sequelae in patients receiving stomatotoxic therapy was not detected on this study...
  33. ncbi Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America
    Thomas J Walsh
    Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA
    Clin Infect Dis 46:327-60. 2008
  34. ncbi Colonization and molecular epidemiology of coagulase-negative Staphylococcal bacteremia in cancer patients: a pilot study
    Silvia F Costa
    , , Brazil
    Am J Infect Control 34:36-40. 2006
    ..CONCLUSION: Mucosa is the most common site of CoNS colonization and is the likely source of CoNS bacteremia in cancer patients...
  35. ncbi Are antimicrobial-impregnated catheters effective? Replace the water and grab your washcloth, because we have a baby to wash
    Scott A McConnell
    School of Pharmacy and Health Related Professions, Creighton University Medical Center, Omaha, NE, USA
    Clin Infect Dis 39:1829-33. 2004
    ....